Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma

<div>Biological processes and KEGG pathways enriched by GSEA. (a) Representative biological processes enriched and (b) KEGG pathways in high- and low-risk HNSCC patients.</div>

BioMed Research International

fig7

Figure 7

Figure 7: Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma 